Kendal K. Whitlock is the Head of Digital Optimization, RWE Clinical Trials, with Walgreens. This role leverages data assets and partnerships to advance culturally responsive approaches to clinical research. In her role, Ms. Whitlock focuses on digital, educational, and community-based solutions to drive access to clinical trials, enabling opportunities that are flexible and convenient for participants.
Ms. Whitlock brings nearly 25 years of pharmaceutical industry experience to this new role. She is thought leader who advocates for digital literacy, health equity, and patient empowerment by applying data-driven methods to customize approaches that address patient/community unmet needs.
Ms. Whitlock holds a Master of Public Health degree in Sociomedical Sciences from Columbia University (New York, NY) and is currently working toward a doctorate. She earned a BA with honors from Spelman College (Atlanta, GA).
Ms. Whitlock has published in peer-reviewed journals, is a global speaker, Co-Lead of the 3C Decentralized Clinical Trials (DCT) Research Curriculum Initiative for the Decentralized Trials Research Alliance (DTRA), Chair of the Product Development and Clinical Research Sub-committee for the Med Tech Color Collaborative Community, member of the Personalized Medicine Coalition (PMC) Health Equity Task Force, Associate Fellow for the 2022-2023 Precision Medicine: Ethics, Politics, and Culture project (Columbia University), member of the NIH-BMGF Innovation Equity Forum Steering Committee, recently named among one of Diversity Woman Media’s Elite 100 Class of 2023, and is the Inaugural Kerry Murphy Healey (KMH) Center Health Innovation Award Recipient (Babson College).
Ms. Whitlock brings nearly 25 years of pharmaceutical industry experience to this new role. She is thought leader who advocates for digital literacy, health equity, and patient empowerment by applying data-driven methods to customize approaches that address patient/community unmet needs.
Ms. Whitlock holds a Master of Public Health degree in Sociomedical Sciences from Columbia University (New York, NY) and is currently working toward a doctorate. She earned a BA with honors from Spelman College (Atlanta, GA).
Ms. Whitlock has published in peer-reviewed journals, is a global speaker, Co-Lead of the 3C Decentralized Clinical Trials (DCT) Research Curriculum Initiative for the Decentralized Trials Research Alliance (DTRA), Chair of the Product Development and Clinical Research Sub-committee for the Med Tech Color Collaborative Community, member of the Personalized Medicine Coalition (PMC) Health Equity Task Force, Associate Fellow for the 2022-2023 Precision Medicine: Ethics, Politics, and Culture project (Columbia University), member of the NIH-BMGF Innovation Equity Forum Steering Committee, recently named among one of Diversity Woman Media’s Elite 100 Class of 2023, and is the Inaugural Kerry Murphy Healey (KMH) Center Health Innovation Award Recipient (Babson College).
Speaking In
2:15 PM - 3:15 PM
Monday, June 5
